|
Volumn 129, Issue 2, 2012, Pages 566-567
|
Medical and economic impact of misdiagnosis of drug hypersensitivity in hospitalized patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
BETA LACTAM ANTIBIOTIC;
CYCLOOXYGENASE 2 INHIBITOR;
IODINATED CONTRAST MEDIUM;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
QUINOLONE;
VANCOMYCIN;
ABDOMINAL PAIN;
ANTIBIOTIC THERAPY;
COST OF ILLNESS;
DELAYED HYPERSENSITIVITY;
DIAGNOSTIC ERROR;
DIAGNOSTIC VALUE;
DIARRHEA;
DIGESTIVE SYSTEM HEMORRHAGE;
DRUG CHOICE;
DRUG COST;
DRUG HYPERSENSITIVITY;
DRUG SUBSTITUTION;
DRUG TOLERABILITY;
DRUG TOLERANCE;
DRUG WITHDRAWAL;
ELECTRONIC MEDICAL RECORD;
FEMALE;
HEALTH CARE COST;
HOSPITAL PATIENT;
HUMAN;
IMMEDIATE TYPE HYPERSENSITIVITY;
INTRACUTANEOUS TEST;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL HISTORY;
PRICK TEST;
PRIORITY JOURNAL;
PROVOCATION TEST;
SKIN MANIFESTATION;
TERTIARY HEALTH CARE;
VALIDITY;
|
EID: 84856455450
PISSN: 00916749
EISSN: 10976825
Source Type: Journal
DOI: 10.1016/j.jaci.2011.09.028 Document Type: Article |
Times cited : (39)
|
References (4)
|